MAIA Biotechnology Inc. (MAIA)
MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology
MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology
PrEP Wisdom: ViiV Healthcare Launches New Campaign to Support Informed HIV Prevention Choices
Viking Names Newest Ocean Ship in Italy
Venu Holding Corporation to Join Russell 3000 Index
Shake Shack to Participate in June Investor Conferences
ACA Group Appoints Trey Loughran as Chief Executive Officer
Barings BDC, Inc. Announces Early Termination of Sierra Credit Support Agreement and $67.0 Million Payment From Barings LLC
TRWD Relocates Corporate Headquarters to Las Vegas, Nevada
PagerDuty to Present at the Bank of America Securities 2026 Global Technology Conference
Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research USA - English APAC - English